Previous Close | 0.1600 |
Open | 0.2600 |
Bid | 0.1400 |
Ask | 0.1900 |
Strike | 129.00 |
Expire Date | 2024-06-28 |
Day's Range | 0.1300 - 0.2600 |
Contract Range | N/A |
Volume | |
Open Interest | 1.59k |
RAHWAY, N.J., June 25, 2024--Merck Animal Health, known as MSD Animal Health outside of the United States and Canada, a division of Merck & Co., Inc., Rahway, N.J., USA (NYSE:MRK), announced today the U.S. Department of Agriculture (USDA) approval of NOBIVAC® NXT Canine Flu H3N2, a next-level solution to help safeguard dogs against the ongoing threat of canine influenza. The product is expected to be available at veterinary clinics and hospitals nationwide late this summer.
Merck (MRK) closed the most recent trading day at $132.96, moving +1.71% from the previous trading session.
We recently compiled a list of the 10 Best Healthcare Stocks to Buy According to Hedge Funds. In this article, we are going to take a look at where Merck & Co., Inc. (NYSE:MRK) stands against the other healthcare stocks. You can also check out the 20 Most Valuable Healthcare Companies in the World here. Healthcare […]